ACCENT IA Crohn’s Disease Clinical Trial Evaluating Ifliximab in a New Long-Term Treatment Regimen. A trial assessing the efficacy of immunosuppression (infliximab) in managing Crohn’s disease.
Conclusion Infliximab may improve symptoms of Crohn’s disease.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.